For over four decades, the global fight against HIV has revolved around managing—not curing—the virus. Antiviral therapies (ART) have proven profoundly effective at suppressing HIV’s replication and keeping millions alive, but they’re not a cure. The reason? HIV’s most cunning move: it hides.
Inside the body, the virus enters a dormant state, embedding itself within resting T cells—critical immune cells that act like sanctuaries for HIV’s genetic code. These infected cells lie in wait, invisible to the immune system, untouched by antivirals. As soon as treatment is stopped, the virus reawakens. That is the frustrating truth of HIV: it can disappear, but it never really leaves.
Now, a world-first discovery from Australia might be rewriting that truth.
In a breakthrough that’s making global headlines, researchers at the Peter Doherty Institute for Infection and Immunity have used mRNA technology—the same platform that powered COVID-19 vaccines—to reverse HIV latency. The research was led by Laureate Professor Sharon Lewin, a leading global voice in HIV science and President of the International AIDS Society.
“We made mRNA which instructed the cell to activate HIV, while not activating any other gene,” says Professor Lewin. “That’s never been possible before with conventional drugs.”
The Problem with the “Hidden Virus”
Antivirals are remarkable, but incomplete. They stop the virus from multiplying, allowing people with HIV to lead full, healthy lives—but only as long as the medication continues.
“The reason current treatment doesn’t cure HIV is because the virus goes into hiding inside blood cells,” Professor Lewin explains. “It effectively goes into hibernation mode, and the infected cell is no longer visible to the immune system.”
Waking up those hidden viruses—a process called latency reversal—is one of the most critical and long-pursued strategies toward a real cure. But until now, we lacked the tools to target the virus in its sanctuary without activating other genes or causing harmful side effects.
That’s where mRNA steps in.
The Power of mRNA—and the Fat Bubble That Delivers It
This time, researchers used messenger RNA (mRNA) not to fight a virus, but to speak to it.
The team designed mRNA to deliver a specific instruction: “Wake up.”
Only to HIV. Nothing else.
To get that message into the right cells, the team developed LNP-X—a novel lipid nanoparticle (LNP) that functions like a microscopic fat bubble. Its job: shield the mRNA and ensure it reaches resting T cells, where HIV hides.
“Our discovery was finding a fat bubble that could efficiently deliver mRNA to a resting T cell,” says Lewin. “These are cells that don’t take up foreign things easily. It was a real challenge.”
Not a Cure—Yet
For now, the results exist only in laboratory models. No human trials have begun, and much work lies ahead.
“These are exciting findings and an advance in the field, but the experiments have only been done in test tube models so far,” Lewin cautions. “There are still many more steps needed to work out if this approach is safe and effective.”
She’s quick to reaffirm that antiviral therapy remains essential. “Access to antivirals must be a priority for the global community now,” she says. “Treatment should be continued indefinitely for all people with HIV.”
But make no mistake—this is a breakthrough.
The ability to deliver mRNA to HIV’s hiding place with such specificity opens doors scientists have knocked on for years. It means HIV could someday be “unmasked” from within, and finally flushed out.
Reimagining HIV Treatment—and Public Understanding
Part of Professor Lewin’s work isn’t just about science—it’s about managing hope.
“Reversing latency is only one of many strategies to achieve a cure,” she says. “Activating an effective HIV-specific immune response will probably also be needed.”
This includes vaccines, which she believes could play a role not just in prevention, but cure—by energising the immune system to fight back once the virus is exposed.
At the same time, the team is working to refine LNP-X to make it even more efficient. One promising method involves tagging the outside of the fat bubble to help it navigate directly to the correct immune cells. Another uses additional lipids to make the particles “stealthy,” allowing them to bypass the liver and stay in circulation longer.
“We have a few tricks up our sleeve that we’re currently testing,” she says.
The Road Ahead
This isn’t the end of the fight, but it’s a new beginning. One built not on managing the virus, but on understanding its deepest behaviors and finding ways to undo its invisibility.
The next stages will involve animal models, careful safety studies, and—eventually—clinical trials in people. Still, the discovery has already ignited the global HIV research community with hope.
In the end, Professor Lewin doesn’t just want to wake the virus—she wants to change the way the world sees HIV.
“The immune system is never quite normal in someone with HIV, even on effective therapy,” she says. “If we can activate the right immune response and remove every infected cell, then we may one day see a world where lifelong treatment is no longer necessary.”
—
🧪 Published Exclusively on Great Stories
📍 Reported by Journalist Rhea Dadinath
🎓 Source: Professor Sharon Lewin, University of Melbourne & Peter Doherty Institute